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However, estimates of the magnitude vary considerably.1 For 
example; in Bangladesh2 PD morbidity rates range from 0,6 
to 0.8%, in Guatemala a PD annual rate of 0.014/100 children 
was reported3 and in India,4 Vietnam5 and Zimbabwe6 re­
ported rates were 6.3, 5.3 and 6.0%, respectively.
This study was carried out from May through September,
1993, the months of greatest incidence of diarrhea to support 
and orient the activities of the Mexican Diarrhea Program. 
The reported prevalence of PD was obtained from a national 
representative cross-sectional household survey (methods 
published elsewhere7) of children less than 5 years of age. Of 
the 20 935 houses visited, in 7504 households at least one 
child younger than 5 years of age was found (N -  10 700 
children).
Of the 10 700 children 1034 had diarrhea (defined as more 
than 3 liquid evacuations during 24 hours with or without 
blood) at the time of interview (prevalence rate, 9.6/100 
children). Of these, 19 had PD (defined as diarrhea for more 
than 14 days), a prevalence rate of 1.8/100 children with 
diarrhea. Ages of children with PD ranged from 3 to 53 
months (mean value, 22 months). The median length of 
diarrhea episodes was 24 days ± 6.7; range from 14 to more 
than 30 days (PD episode was determined considering outset, 
end and interview dates). The highest frequency was found in 
the 1 to 2-year-old group (36.8%) and in males (78.9%).
All 19 mothers of children with PD knew the recommended 
electrolyte solutions to use from information given by the 
Mexican Diarrhea Program and 75% used it during the 
episodes of diarrhea. In most cases oral rehydration solution 
was administered for 2 days, except for one case in which the 
patient received it for 7 days. Breast-feeding was suspended 
in 3 cases and only one child ceased the intake of food. The use 
of drugs was reported in 9 cases: antibiotics (6 children); 
antidiarrheics (2 children); and antiparasitics (1 child).
Based on the approximate 2% prevalence of PD among 
children with diarrhea, an estimated 4000 cases of PD could 
occur each year in Mexico among children less than 5 years of 
age. Although this study detected only cured or mild cases of 
diarrhea and PD rate could be underestimated because we 
considered only PD cases at the time of the interview, the 
importance of this study is that the reported PD prevalence 
rate was obtained from a national representative survey 
instead of studies in specific communities with captive popu­
lations, placing Mexico as a country with an intermediate risk 
for PD when compared with other developing countries.
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HUMAN HERPESVIRUS 6 MONONUCLEOSIS AND
SEIZURES
To The Editors:
Human herpesvirus 6 (HHV-6) has been identified as the 
causative agent of exanthema subitum.1 In children this 
disease is often complicated by the presence of febrile sei­
zures. HHV-6 is furthermore associated with seizures of a 
complex or recurrent course.2 In adolescents and adults 
HHV-6 infection may present with fever and mononucleosis 
but without seizures,3
An 11-month-old boy was admitted to our hospital because 
of a complex seizure which lasted for more than 1 hour, 
despite two doses of diazepam and one of clonazepam. Only 
after 100 mg of phenytoin intravenously did the convulsion 
come under control. At the time of admission the boy had a 
temperature of 40.2°C, hepatomegaly, a slightly broadened 
mediastinum on the chest radiograph and hematologic abnor­
malities that prompted suspicion of leukemia. Anemia (Hb 
9.5 g/dl), and leukopenia (leukocyte count 1.9 X 109/liter) 
were present with 30% polymorphonuclear cells, 49% small 
lymphocytes, 6% atypical lymphocytes, 3% blast forms, 1% 
plasma cells and 11% monocytes. Platelet count was normal.
Because of the suspicion of leukemia the boy was referred 
to the Academic Hospital Nijmegen. A bone marrow aspirate 
showed normal bone marrow with 7% young monocytes. A 
second aspirate 4 days later was normal. These results were 
confirmed by the Dutch Childhood Leukemia Study Group.
The child was readmitted to the referring hospital for 
further evaluation of the underlying cause. Viral cultures 
taken at the first admission remained negative but serology 
was indicative for a recent HHV-6 infection (Table). Thus 
primary HHV-6 infection in young children may present with 
changes in peripheral blood indicative of mononucleosis and 
may be possibly confused with acute leukemia.
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TABLE 1. Serologic Investigations
CMV, HSV and VZV serology was performed by ELISA, expressed for IgG in AU and for IgM and IgA qualitatively. EBV and 
HHV-6 serology was performed by indirect immunofluorescence and expressed as titers (see Reference 4).
Time after 
Onset of 
Febrile 
Convulsion
CMV EBV-VCA HHV-6 
IgG IgM
HSV VZV
IgAIgG (AU) IgM IgA IgG IgM IgG (AU) IgM IgA IgG (AU) IgM
Day 3 88 Neg Neg < 1:8 < 1:10 <1:5 < 1:10 <4 Neg Neg <4 Neg Neg
Day 9 NT Neg Neg < 1:8 < 1:10 1:20 1:40 <4 Neg Neg <4 Neg Neg
4 months 92 Neg Neg < 1:8 < 1:10 1:20 < 1:10 <4 Neg Neg <4 Neg Neg
Nog, negative; NT, not tested; CMV, cytomegalovirus; EBV, Epstein-Barr virus; VCA, viral capsid antigen; HSV, herpes simplex vims; VZV, varicella-zoster virus; AUi arhitrary 
units.
3.
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ALCALIGENES XYLOSOXIDANS-ASSOCIATED 
INFECTION IN AN INFANT WITH CHOLESTEATOMA
To The Editors:
Alcaligenes xylosoxidans is emerging as an important nos­
ocomial pathogen, predominantly among immunocompro­
mised patients.1,2 We report on, to our knowledge, the first 
case of A  xylosoxidans chronic otitis media with cholestea­
toma in a nonimmunocompromised child.
In January, 1994, a 6-year-old girl was referred to the 
Robert Debre Pediatric University Hospital in Paris for otal­
gia and otorrhea. She also complained of headache and 
vertigo. Examination revealed a purulent discharge in the 
right external auditory canal and a right-sided otitis media. 
The discharge persisted despite various antibiotic therapies 
including local colistin and two 10-day courses of oral amoxi- 
cillin-clavulanate (50 mg/kg/day). She complained of an in­
creasing postauricular pain and returned in April, 1994, for 
further investigation. On admission otoscopic examination 
revealed a stenotic right external auditory canal. Medial to 
the stenosis was a massive cholesteatoma with obliteration of 
the middle ear. The cholesteatoma was treated by surgical 
excision. Cholesteatoma was confirmed histologically. The 
patient recovered after 7 days of treatment with intravenous 
piperacillin (300 mg/kg/day). Culture of the ear discharge in 
January and then pre- and postoperatively in April showed 
heavy growth of Gram-negative microorganisms on nutrient 
agar. It was identified as A. xylosoxidans subsp. xylosoxidans 
using API 20 NE (Profile No. 1042477). Sensitivity to antimi­
crobials was determined by the disk diffusion method. The 
organism was susceptible to ticarcillin, piperacillin, ticarcillin 
plus clavulanic acid, ceftazidime and imipenem but was 
resistant to cefsulodine, cefotaxime, amoxicillin-clavulanate, 
aztreonam, pefloxacin, ciprofloxacin and aminoglycosides.
The three isolates obtained from our patient were com­
pared with six unrelated isolates by the randomly amplified 
polymorphic DNA (RAPD) method. A. xylosoxidans was sub­
cultured overnight at 30°C on trypticase agar plates. A single 
colony was inoculated into brain-heart infusion broth and 
grown overnight at 30°C. Cells were pelleted by centrifuga­
tion and washed in saline; after further centrifugation the 
supernatant was discarded and the cell pellet was resus­
pended in distilled water at ODfi00 nm 1. This suspension was
used in the amplification reaction. The polymerase chain 
reaction primer 5'-GCC CCC AGG GGC ACA GT-3' was used 
for the RAPD procedure adapted from the procedure of 
Williams et al.3 The amplification procedure was done as 
reported previously.4 The three isolates obtained from our 
patient exhibited indistinguishable patterns (Fig. 1 , Lanes 3 
through 5). The six epidemiologically unrelated isolates pro­
duced distinct pattern (Lane 2 and Lanes 6 through 10), 
Before the current study RAPD analysis had not been applied 
to the study of A. xylosoxidans isolates in pediatric patients.
A. xylosoxidans (formerly Achromobacte?' xylosoxidans) is a 
nonfermentative Gram-negative bacterium. The organism is 
isolated from a wide variety of aquatic environmental 
sources. This microorganism is generally considered innocu­
ous in clinical settings; however, during the last decade a 
number of sporadic cases of human infections caused by this 
organism have been reported.1 Colonization and/or infection 
occur in immunocompromised patients through contaminated 
water, antiseptic solutions, materials or wet su rfaces.2> 5 A  
xylosoxidans has been described as the etiologic agent in cases 
of catheter-associated infection in an infant,5 meningitis6 and 
bacteremia.1,2 A xylosoxidans has not been reported previously 
as a pathogen in chronic ear discharge with cholesteatoma.7,8
The pathogenic character of an opportunistic organism is 
related to the persistence of the same clinical strain when 
several samples were cultured. Until recently epidemiologic 
studies of A. xylosoxidans have been based essentially on 
the study of phenotypic traits. However, none of these 
methods has been found to be really satisfactory for the 
typing of A xylosoxidans because of the insufficient dis­
crimination, poor reproducibility or lack of availability of
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F ig . 1 . A. xylosoxidans DNA fingerprinting by Random PCR. 
Lane 1, size marker; Lane 3, January ear isolate; Lane 4 , 
preoperative ear isolate; Lane 5, postoperative ear isolate; Lane 2 
and Lanes 6 through 10, epidemiologically unrelated isolates, kb, 
kilobases.
